Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:1263-1266
© 1999 American Heart Association, Inc.
Atherosclerosis and Lipoproteins |
Enhanced In Vivo Lipid Peroxidation at Elevated Plasma Total Homocysteine Levels
From the Research Institute of Public Health, University of Kuopio, Kuopio, Finland (S.V., K.N., J.T.S.), the Division of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN (J.D.M., L.J.R.), the Departments of Nutrition (G.A.), and Mental Health and Alcohol Research (H.A.), National Public Health Institute, Helsinki, Finland.
Correspondence to Dr J.T. Salonen, Research Institute of Public Health, University of Kuopio, PO Box 1627, 70211 Kuopio, Finland. E-mail Salonen{at}reivi.uku.fi
Abstract—An
elevated plasma total homocysteine level (tHcy) is considered an
independent risk factor for atherosclerosis. The
mechanisms by which hyperhomocysteinemia induces
atherosclerosis are only partially understood, but
promotion of LDL oxidation and endothelial injury have
been suggested. The purpose of this study was to test the hypothesis
that a high plasma tHcy is associated in men with increased in vivo
lipid peroxidation, as measured by plasma F2-isoprostane
concentrations. We investigated this association in a subset of the
participants in the Antioxidant Supplementation in
Atherosclerosis Prevention (ASAP) study. Of 256 male
participants, a subsample of 100 consecutive men was selected for
F2-isoprostane assays. The mean tHcy was 11.0
µmol/L, and the mean F2-isoprostanes was 29.6 ng/L. The
simple correlation coefficient for association between tHcy and
F2-isoprostane was 0.40 (P<0.001). In a
linear regression model, the variables with the strongest
associations with F2-isoprostane were tHcy (standardized
coefficient 0.33, P<0.001), serum
triglycerides (0.21, P=0.042),
carbohydrate-deficient transferrin (0.15, P=0.132), and
plasma lipid-standardized 
-tocopherol (-0.11,
P=0.252) (R2=0.24,
P<0.001 for model). Plasma F2-isoprostane
levels increased linearly across quintiles of tHcy
(P<0.001). The unadjusted mean (95% confidence
interval) F2-isoprostanes was 47.5% greater in the highest
tHcy quintile (37.4, 31.1 to 43.6 ng/L) than in the lowest quintile
(25.3, 21.3 to 29.3 ng/L). Adjustment for the strongest other
determinants of F2-isoprostane reduced this difference to
28.2% (P=0.010). Our present data suggest that
elevated fasting plasma tHcy is associated with enhanced in vivo lipid
peroxidation in men.
Key Words: homocysteine • F2-isoprostanes • lipid peroxidation • cardiovascular diseases
This article has been cited by other articles:
 |
|
 |
|
  S. K. Park, M. S. O'Neill, P. S. Vokonas, D. Sparrow, A. Spiro III, K. L. Tucker, H. Suh, H. Hu, and J. Schwartz Traffic-related Particles Are Associated with Elevated Homocysteine: The VA Normative Aging Study Am. J. Respir. Crit. Care Med., August 1, 2008; 178(3): 283 - 289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Timm and J. L. Slavin Dietary Fiber and the Relationship to Chronic Diseases American Journal of Lifestyle Medicine, June 1, 2008; 2(3): 233 - 240. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Fisher, K. Lees, and J. D. Spence Nutrition and Stroke Prevention Stroke, September 1, 2006; 37(9): 2430 - 2435. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Morrow Quantification of Isoprostanes as Indices of Oxidant Stress and the Risk of Atherosclerosis in Humans Arterioscler. Thromb. Vasc. Biol., February 1, 2005; 25(2): 279 - 286. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Wu and L. L. Wu Association of Soluble Markers with Various Stages and Major Events of Atherosclerosis Ann. Clin. Lab. Sci., January 1, 2005; 35(3): 240 - 250. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Tesoriere, D. Butera, A. M. Pintaudi, M. Allegra, and M. A Livrea Supplementation with cactus pear (Opuntia ficus-indica) fruit decreases oxidative stress in healthy humans: a comparative study with vitamin C Am. J. Clinical Nutrition, August 1, 2004; 80(2): 391 - 395. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Wu, N. Rifai, L. J. Roberts II, W. C. Willett, and E. B. Rimm Stability of Measurements of Biomarkers of Oxidative Stress in Blood Over 36 Hours Cancer Epidemiol. Biomarkers Prev., August 1, 2004; 13(8): 1399 - 1402. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Hirsch, A. M. Ronco, M. Vasquez, M. P. de la Maza, A. Garrido, G. Barrera, V. Gattas, A. Glasinovic, L. Leiva, and D. Bunout Hyperhomocysteinemia in Healthy Young Men and Elderly Men with Normal Serum Folate Concentration Is Not Associated with Poor Vascular Reactivity or Oxidative Stress J. Nutr., July 1, 2004; 134(7): 1832 - 1835. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Soinio, J. Marniemi, M. Laakso, S. Lehto, and T. Ronnemaa Elevated Plasma Homocysteine Level Is an Independent Predictor of Coronary Heart Disease Events in Patients with Type 2 Diabetes Mellitus Ann Intern Med, January 20, 2004; 140(2): 94 - 100. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Rodrigo, W. Passalacqua, J. Araya, M. Orellana, and G. Rivera Homocysteine and Essential Hypertension J. Clin. Pharmacol., December 1, 2003; 43(12): 1299 - 1306. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Bagi, C. Cseko, E. Toth, and A. Koller Oxidative stress-induced dysregulation of arteriolar wall shear stress and blood pressure in hyperhomocysteinemia is prevented by chronic vitamin C treatment Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2277 - H2283. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Sebekova, M. Krajcovicova-Kudlackova, P. Blazicek, V. Parrak, R. Schinzel, and A. Heidland Functional Hyperhomocysteinemia in Healthy Vegetarians: No Association with Advanced Glycation End Products, Markers of Protein Oxidation, or Lipid Peroxidation after Correction with Vitamin B12 Clin. Chem., June 1, 2003; 49(6): 983 - 986. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Wang, X. Jiang, F. Yang, J. W. Gaubatz, L. Ma, M. J. Magera, X. Yang, P. B. Berger, W. Durante, H. J. Pownall, et al. Hyperhomocysteinemia accelerates atherosclerosis in cystathionine beta -synthase and apolipoprotein E double knock-out mice with and without dietary perturbation Blood, May 15, 2003; 101(10): 3901 - 3907. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. V. Higdon and B. Frei Obesity and Oxidative Stress: A Direct Link to CVD? Arterioscler. Thromb. Vasc. Biol., March 1, 2003; 23(3): 365 - 367. [Full Text] [PDF]
|
|
|
|
|
|
J. D. Morrow Is Oxidant Stress a Connection Between Obesity and Atherosclerosis? Arterioscler. Thromb. Vasc. Biol., March 1, 2003; 23(3): 368 - 370. [Full Text] [PDF]
|
|
|
|
 |
|
 B. Bayes, M. C. Pastor, J. Bonal, J. Junca, J. M. Hernandez, N. Riutort, A. Foraster, and R. Romero Homocysteine, C-reactive protein, lipid peroxidation and mortality in haemodialysis patients Nephrol. Dial. Transplant., January 1, 2003; 18(1): 106 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Minuz, P. Patrignani, S. Gaino, M. Degan, L. Menapace, R. Tommasoli, F. Seta, M. L. Capone, S. Tacconelli, S. Palatresi, et al. Increased Oxidative Stress and Platelet Activation in Patients With Hypertension and Renovascular Disease Circulation, November 26, 2002; 106(22): 2800 - 2805. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Schnyder, Y. Flammer, M. Roffi, R. Pin, and O. M. Hess Plasma homocysteine levels and late outcome after coronary angioplasty J. Am. Coll. Cardiol., November 20, 2002; 40(10): 1769 - 1776. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Fontana, C. Giagulli, L. Cominacini, A. F. Pasini, P. Minuz, A. Lechi, A. Sala, and C. Laudanna {beta}2 Integrin-Dependent Neutrophil Adhesion Induced by Minimally Modified Low-Density Lipoproteins Is Mainly Mediated by F2-Isoprostanes Circulation, November 5, 2002; 106(19): 2434 - 2441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Tawakol, M. A. Forgione, M. Stuehlinger, N. M. Alpert, J. P. Cooke, J. Loscalzo, A. J. Fischman, M. A. Creager, and H. Gewirtz Homocysteine impairs coronary microvascular dilator function in humans J. Am. Coll. Cardiol., September 18, 2002; 40(6): 1051 - 1058. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Schnyder, M. Roffi, Y. Flammer, R. Pin, and O. M. Hess Effect of Homocysteine-Lowering Therapy With Folic Acid, Vitamin B12, and Vitamin B6 on Clinical Outcome After Percutaneous Coronary Intervention: The Swiss Heart Study: A Randomized Controlled Trial JAMA, August 28, 2002; 288(8): 973 - 979. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Kelly, J. Rosand, J. P. Kistler, V. E. Shih, S. Silveira, A. Plomaritoglou, and K. L. Furie Homocysteine, MTHFR 677C->T polymorphism, and risk of ischemic stroke: Results of a meta-analysis Neurology, August 27, 2002; 59(4): 529 - 536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Weiss, C. Keller, U. Hoffmann, and J. Loscalzo Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia Vascular Medicine, August 1, 2002; 7(3): 227 - 239. [Abstract] [PDF]
|
|
|
|
 |
|
 Z. Ungvari, A. Csiszar, Z. Bagi, and A. Koller Impaired Nitric Oxide-Mediated Flow-Induced Coronary Dilation in Hyperhomocysteinemia : Morphological and Functional Evidence for Increased Peroxynitrite Formation Am. J. Pathol., July 1, 2002; 161(1): 145 - 153. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P R J Ames, A Margarita, J D. Alves, C Tommasino, L Iannaccone, and V Brancaccio Anticardiolipin antibody titre and plasma homocysteine level independently predict intima media thickness of carotid arteries in subjects with idiopathic antiphospholipid antibodies Lupus, April 1, 2002; 11(4): 208 - 214. [Abstract] [PDF]
|
|
|
|
|
|
Z. Bagi, Z. Ungvari, and A. Koller Xanthine Oxidase-Derived Reactive Oxygen Species Convert Flow-Induced Arteriolar Dilation to Constriction in Hyperhomocysteinemia: Possible Role of Peroxynitrite Arterioscler. Thromb. Vasc. Biol., January 1, 2002; 22(1): 28 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Jang, J. H. Lee, O. Y. Kim, H. Y. Park, and S. Y. Lee Consumption of Whole Grain and Legume Powder Reduces Insulin Demand, Lipid Peroxidation, and Plasma Homocysteine Concentrations in Patients With Coronary Artery Disease: Randomized Controlled Clinical Trial Arterioscler. Thromb. Vasc. Biol., December 1, 2001; 21(12): 2065 - 2071. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Svenungsson, K. Jensen-Urstad, M. Heimburger, A. Silveira, A. Hamsten, U. de Faire, J. L. Witztum, and J. Frostegard Risk Factors for Cardiovascular Disease in Systemic Lupus Erythematosus Circulation, October 16, 2001; 104(16): 1887 - 1893. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Davi, G. Di Minno, A. Coppola, G. Andria, A. M. Cerbone, P. Madonna, A. Tufano, A. Falco, P. Marchesani, G. Ciabattoni, et al. Oxidative Stress and Platelet Activation in Homozygous Homocystinuria Circulation, September 4, 2001; 104(10): 1124 - 1128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. N. Doshi, I. F. W. McDowell, S. J. Moat, D. Lang, R. G. Newcombe, M. B. Kredan, M. J. Lewis, and J. Goodfellow Folate Improves Endothelial Function in Coronary Artery Disease : An Effect Mediated by Reduction of Intracellular Superoxide? Arterioscler. Thromb. Vasc. Biol., July 1, 2001; 21(7): 1196 - 1202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.C. Chambers and J.S. Kooner Homocysteine -- an innocent bystander in vascular disease? Eur. Heart J., May 1, 2001; 22(9): 717 - 719. [PDF]
|
|
|
|
|
|
P.a. Aukrust, R. K. Berge, T. Ueland, E. Aaser, J. K. Damas, L. Wikeby, A. Brunsvig, F. Muller, K. Forfang, S. S. Froland, et al. Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes J. Am. Coll. Cardiol., February 1, 2001; 37(2): 485 - 491. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Fontana, C. Giagulli, P. Minuz, A. Lechi, and C. Laudanna 8-Iso-PGF2{{alpha}} Induces {beta}2-Integrin-Mediated Rapid Adhesion of Human Polymorphonuclear Neutrophils : A Link Between Oxidative Stress and Ischemia/Reperfusion Injury Arterioscler. Thromb. Vasc. Biol., January 1, 2001; 21(1): 55 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. H. A. F. de Man, I. J. A. M. Jonkers, E. Schwedhelm, A. H. M. Smelt, W. Onkenhout, W. van Duyvenvoorde, R. Buytenhek, J. A. G. Leuven, R. Troost, A. van der Laarse, et al. Normal Oxidative Stress and Enhanced Lipoprotein Resistance to In Vitro Oxidation in Hypertriglyceridemia : Effects of Bezafibrate Therapy Arterioscler. Thromb. Vasc. Biol., November 1, 2000; 20(11): 2434 - 2440. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Halliwell Lipid peroxidation, antioxidants and cardiovascular disease: how should we move forward? Cardiovasc Res, August 18, 2000; 47(3): 410 - 418. [Full Text] [PDF]
|
|
|
|
|
|
D. W. Jacobsen Hyperhomocysteinemia and Oxidative Stress : Time for a Reality Check? Arterioscler. Thromb. Vasc. Biol., May 1, 2000; 20(5): 1182 - 1184. [Full Text] [PDF]
|
|
|
|
|
|
M. A. Mansoor, C. Bergmark, S. J. Haswell, I. F. Savage, P. H. Evans, R. K. Berge, A. M. Svardal, and O. Kristensen Correlation between Plasma Total Homocysteine and Copper in Patients with Peripheral Vascular Disease Clin. Chem., March 1, 2000; 46(3): 385 - 391. [Abstract] [Full Text] [PDF]
|
|